Browse Studies — Arctuva

Phase 2

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease With Chronic Bronchitis (SCALA)

The purpose of the study is to investigate the efficacy of galvokimig versus placebo in the time to the first acute exacerbation of chronic obstructive pulmona…

Chronic Obstructive Pulmonary Disease With Chronic Bronchitis

Estimated

~$10 – $8,750

UCB Biopharma SRLNCT07725939

Emphysema Research Registry; Screening Study and Genetic Testing

The Comprehensive Lung Center (CLC) at the University of Pittsburgh Medical Center (UPMC Health System) provides patients with any type of breathing or lung di…

EmphysemaChronic Obstructive Pulmonary DiseaseChronic Bronchitis

Estimated

~$10 – $750

University of PittsburghNCT00307281

COPD Patient-Powered Research Network

The COPD Patient-Powered Research Network (COPD PPRN) is a patient research registry with the goal of enrolling 75,000 or more COPD patients and those at risk …

Chronic Obstructive Pulmonary DisorderChronic Obstructive Lung DiseaseEmphysema+1 more

Estimated

~$10 – $750

COPD FoundationNCT02803242